These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 12522585)

  • 21. [The role of dynamic observation in the prevention of recurrences of stone formation].
    Dzeranov NK; Darenkov AF; Konstantinova OV; Beshliev DA; Borisik VI; Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1998; (2):12-4. PubMed ID: 9577694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal management of urolithiasis in renal transplantation.
    Challacombe B; Dasgupta P; Tiptaft R; Glass J; Koffman G; Goldsmith D; Khan MS
    BJU Int; 2005 Aug; 96(3):385-9. PubMed ID: 16042735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracorporeal shockwave lithotripsy in infants.
    Ramakrishnan PA; Medhat M; Al-Bulushi YH; Nair P; Al-Kindy A
    Can J Urol; 2007 Oct; 14(5):3684-91. PubMed ID: 17949522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrent oxalocalcium lithiasis. 2: Risk factors and prevention of recurrence of calcium urinary lithiasis].
    Réveillaud RJ; Daudon M
    Rev Prat; 1989 Feb; 39(4):317-23. PubMed ID: 2649970
    [No Abstract]   [Full Text] [Related]  

  • 25. [What foods should stone formers avoid?].
    Amasaki N; Kurita T
    Hinyokika Kiyo; 2004 Aug; 50(8):573-5. PubMed ID: 15471079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Medical treatment of urinary lithiasis].
    Cachat F; Barbey F; Daudon M
    Rev Med Suisse Romande; 2004 Aug; 124(8):461-4. PubMed ID: 15495468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Calcium kidney stones. Diagnostic and preventive prospects].
    Arcidiacono T; Terranegra A; Biasion R; Soldati L; Vezzoli G
    G Ital Nefrol; 2007; 24(6):535-46. PubMed ID: 18278757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children.
    Seyhan S; Yavascaoglu I; Kilicarslan H; Dogan HS; Kordan Y
    Int J Urol; 2007 Dec; 14(12):1060-2. PubMed ID: 18036039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
    Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
    Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of carbohydrate-electrolyte sports beverages on urinary stone risk factors.
    Sweeney DD; Tomaszewski JJ; Ricchiuti DD; Averch TD
    J Urol; 2009 Sep; 182(3):992-7. PubMed ID: 19616798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obesity and urolithiasis.
    Asplin JR
    Adv Chronic Kidney Dis; 2009 Jan; 16(1):11-20. PubMed ID: 19095201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathogenesis and prevention of calcium-salt urolithiasis].
    Trybulski T; Syc S
    Wiad Lek; 1972 Sep; 25(18):1675-8. PubMed ID: 4563906
    [No Abstract]   [Full Text] [Related]  

  • 34. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?
    Tiselius HG
    Urolithiasis; 2016 Feb; 44(1):91-100. PubMed ID: 26614110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical composition of urinary calculi in Maiduguri, Nigeria.
    Mshelia DS; Gali BM; Naaya UH; Habu SA
    Afr J Med Med Sci; 2005 Jun; 34(2):185-8. PubMed ID: 16749345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Possibilities and limitations in the prevention of urolithiasis from the pediatric viewpoint].
    Wässer S; Hauschild G; Schöne D
    Zentralbl Chir; 1971 Jan; 96(4):136-42. PubMed ID: 5554821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.